Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study
Dunya Tomic(Baker Heart and Diabetes Institute), Dianna J. Magliano(Monash University), Agus Salim(Baker Heart and Diabetes Institute), Sonsoles Fuentes(Santé Publique France), Dı́dac Mauricio(Universitat de Vic - Universitat Central de Catalunya), Yiling J. Cheng(Centers for Disease Control and Prevention), Bendix Carstensen(Steno Diabetes Centers), Marta Baviera(Mario Negri Institute for Pharmacological Research), Lei Chen(Union Hospital), Tomoaki Imamura(Nara Medical University), Jonathan E. Shaw(St Mary's Hospital), Dae Jung Kim(Kingston Health Sciences Centre), Santa Pildava, Alexandra Kautzky‐Willer(Universitätszahnklinik Wien), Andrea O. Y. Luk(Chinese University of Hong Kong), Kyoung Hwa Ha(Yonsei University), Takehiro Sugiyama(University of Tsukuba), Meda E. Pavkov(Government of the United States of America), Maya Leventer‐Roberts(Mount Sinai Health System), Maria Carla Roncaglioni(Mario Negri Institute for Pharmacological Research), Manel Mata‐Cases(Instituto de Salud Carlos III), Anna Peeters(Deakin University), Sarah H. Wild(University of Hohenheim), Annika Hoyer(Bielefeld University), Hanne Løvdal Gulseth, Romualdas Gurevičius(Mykolas Romeris University), Naama Yekutiel(Maccabi Institute for Health Services Research), Jedidiah I Morton(Baker Heart and Diabetes Institute), Hélène Gardiner(Public Health Agency of Canada), Paz Lopez‐Doriga Ruiz(Norwegian Institute of Public Health), Sandrine Fosse‐Edorh(Santé Publique France), Sanjoy K. Paul(University of Leicester), Kang-Ling Wang(National Yang Ming Chiao Tung University), Stuart J. McGurnaghan(University of Edinburgh), Ran D. Balicer(Ben-Gurion University of the Negev), Edward W. Gregg(Imperial College London), Peter Klimek(Karolinska Institutet), Elise Boersma-van Dam(Netherlands Institute for Health Services Research), Ilmo Keskimäki(Finnish Institute for Health and Welfare), Zoltán Kiss(University of Pecs), Juliana C.N. Chan(Chinese University of Hong Kong), Martti Arffman(Finnish Institute for Health and Welfare), Stefan Ma(Ministry of Health), Cynthia Robitaille(Public Health Agency of Canada), György Jermendy(Bajcsy-Zsilinszky Kórház és Rendelőintézet), Chun-Yi Lin(Taipei Veterans General Hospital), Ralph Brinks(Witten/Herdecke University)
Cited by 72
Related Papers
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2017|2.1k
Ranking the effectiveness of worldwide COVID-19 government interventions
|Nature Human Behaviour|2020|1.5k
Runs of Homozygosity in European Populations
|The American Journal of Human Genetics|2008|1.5k
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
|European Heart Journal|2023|1.4k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.3k